Thymic Carcinoma

Also known as: Thymic carcinoma / Carcinoma, Thymic / Thymic Carcinomas / Thymoma malignant / Thymoma malignant NOS / Malignant thymoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00482Celecoxib1Completed1
DB00531Cyclophosphamide1Completed1
DB00619Imatinib1Completed1
DB00482Celecoxib1 / 2Suspended1
DB00515Cisplatin1 / 2Terminated1
DB00531Cyclophosphamide1 / 2Suspended1
DB00531Cyclophosphamide1 / 2Terminated1
DB00997Doxorubicin1 / 2Terminated1
DB09035Nivolumab1 / 2Recruiting1
DB06263Amrubicin2Completed1
DB11945Avelumab2Recruiting1
DB05015Belinostat2Completed1
DB01008Busulfan2Completed1
DB00958Carboplatin2Completed1
DB00958Carboplatin2Recruiting1
DB00002Cetuximab2Active Not Recruiting1
DB00515Cisplatin2Active Not Recruiting1
DB00515Cisplatin2Terminated1
DB00531Cyclophosphamide2Active Not Recruiting1
DB00531Cyclophosphamide2Completed1
DB00091Cyclosporine2Completed1
DB01142Doxepin2Terminated1
DB00997Doxorubicin2Active Not Recruiting1
DB11717Epacadostat2Active Not Recruiting1
DB00530Erlotinib2Active Not Recruiting1
DB01259Lapatinib2Active Not Recruiting1
DB01042Melphalan2Completed1
DB00959Methylprednisolone2Completed1
DB09035Nivolumab2Recruiting1
DB01229Paclitaxel2Completed1
DB01229Paclitaxel2Recruiting1
DB01229Paclitaxel2Terminated1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting1
DB00642Pemetrexed2Completed1
DB05578Ramucirumab2Recruiting1
DB08896Regorafenib2Active Not Recruiting1
DB11689Selumetinib2Active Not Recruiting1
DB01268Sunitinib2Active Not Recruiting1
DB01268Sunitinib2Completed1
DB01268Sunitinib2Recruiting2